Hydralazine
Mechanical Thrombectomy
ProMedica Health SystemSmall moleculePhase 3Active
BB
68/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 55/ 100
- Competitive Position
- 95/ 100
Competitive context
6 Active assets in the Mechanical Thrombectomy cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
LABETALOL ProMedica Health System | Phase 3 | BB |
Lipitor Zhongda Hospital | Phase 4 | BB |
Compound Edaravone Beijing Tiantan Hospital | Phase 3 | BB |
Dexborneol Beijing Tiantan Hospital | Phase 3 | BB |
Clevidipine ProMedica Health System | Phase 3 | BB |
Enalapril Hamilton Health Sciences Corporation | Phase 2 | B |
3-N-BUTYLPHTHALIDE Hui-Sheng Chen | N/A | D |
Same molecule, other indications
Hydralazine is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →